HUP0301865A3 - A method for synthesizing leflunomide - Google Patents
A method for synthesizing leflunomideInfo
- Publication number
- HUP0301865A3 HUP0301865A3 HU0301865A HUP0301865A HUP0301865A3 HU P0301865 A3 HUP0301865 A3 HU P0301865A3 HU 0301865 A HU0301865 A HU 0301865A HU P0301865 A HUP0301865 A HU P0301865A HU P0301865 A3 HUP0301865 A3 HU P0301865A3
- Authority
- HU
- Hungary
- Prior art keywords
- leflunomide
- synthesizing
- synthesizing leflunomide
- Prior art date
Links
- VHOGYURTWQBHIL-UHFFFAOYSA-N leflunomide Chemical compound O1N=CC(C(=O)NC=2C=CC(=CC=2)C(F)(F)F)=C1C VHOGYURTWQBHIL-UHFFFAOYSA-N 0.000 title 1
- 229960000681 leflunomide Drugs 0.000 title 1
- 230000002194 synthesizing effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D261/18—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Diabetes (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Obesity (AREA)
- Ophthalmology & Optometry (AREA)
- Pain & Pain Management (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Dermatology (AREA)
- Transplantation (AREA)
- Otolaryngology (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US18263500P | 2000-02-15 | 2000-02-15 | |
PCT/US2001/004095 WO2001060363A1 (en) | 2000-02-15 | 2001-02-08 | A method for synthesizing leflunomide |
Publications (2)
Publication Number | Publication Date |
---|---|
HUP0301865A2 HUP0301865A2 (hu) | 2003-09-29 |
HUP0301865A3 true HUP0301865A3 (en) | 2005-12-28 |
Family
ID=22669359
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0301865A HUP0301865A3 (en) | 2000-02-15 | 2001-02-08 | A method for synthesizing leflunomide |
Country Status (18)
Country | Link |
---|---|
US (2) | US6723855B2 (hu) |
EP (1) | EP1257270B1 (hu) |
JP (1) | JP2004500380A (hu) |
KR (1) | KR20020072312A (hu) |
AT (1) | ATE292966T1 (hu) |
AU (1) | AU2001234943A1 (hu) |
CA (1) | CA2400290A1 (hu) |
CZ (1) | CZ20023024A3 (hu) |
DE (1) | DE60110043T2 (hu) |
ES (1) | ES2237553T3 (hu) |
HR (1) | HRP20020671A2 (hu) |
HU (1) | HUP0301865A3 (hu) |
IL (1) | IL151196A0 (hu) |
PL (1) | PL366088A1 (hu) |
SK (1) | SK12992002A3 (hu) |
WO (1) | WO2001060363A1 (hu) |
YU (1) | YU61602A (hu) |
ZA (1) | ZA200206494B (hu) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT987256E (pt) * | 1997-08-08 | 2002-03-28 | Aventis Pharma Gmbh | Forma cristalina da n-(4-trifluorometilfenil)-5-metil-isoxazol-4-carboxamida |
IL149792A0 (en) * | 1999-12-16 | 2002-11-10 | Teva Pharma | Novel processes for making and a new crystalline form of leflunomide |
GB0123571D0 (en) * | 2001-04-05 | 2001-11-21 | Aventis Pharm Prod Inc | Use of (Z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluoromethylphenyl)-amide for treating multiple sclerosis |
US20030139606A1 (en) * | 2001-11-09 | 2003-07-24 | Ray Anup Kumar | Process for preparing 5-methylisoxazole-4-carboxylic- (4'-trifluoromethyl)-anilide |
MXPA05012739A (es) * | 2003-05-27 | 2006-05-17 | Robert Per Hagerkvist | Uso de inhibidor de quinasa de tirosina para tratar diabetes. |
WO2005041940A1 (en) * | 2003-10-30 | 2005-05-12 | Lupin Ltd. | Stable formulations of ace inhibitors and methods for preparation thereof |
US20060024376A1 (en) * | 2004-07-30 | 2006-02-02 | The University Of Chicago | Methods and compositions for reducing toxicity associated with leflunomide treatment |
DE102005017592A1 (de) * | 2005-04-16 | 2006-10-19 | Lindner, Jürgen, Dr. med. | Darreichungsformen und Kombinationspräparate von Pyrimidinbiosyntheseinhibitoren zur Erzielung zusätzlicher Wirkungen auf das Immunsystem |
WO2007086076A2 (en) * | 2006-01-24 | 2007-08-02 | Unichem Laboratories Limited | An improved process for preparation of leflunomide |
CN101817797B (zh) * | 2009-02-26 | 2013-04-10 | 江苏亚邦爱普森药业有限公司 | 高纯度3-甲基-n-[4-(三氟甲基)苯基]-4-异噁唑甲酰胺的合成方法 |
RU2012115459A (ru) | 2009-09-18 | 2013-10-27 | Санофи | Таблетируюмый препарат (4'-трифторметилфенил)амида (z)-2-циано-3-гидрокси-бут-2-еноевой кислоты с улучшенной устойчивостью |
CN102002009B (zh) * | 2010-10-18 | 2012-11-07 | 齐鲁制药有限公司 | 一种5-甲基异恶唑-4-甲酰氯的制备方法 |
BR112017027175B1 (pt) | 2015-06-17 | 2022-02-08 | Biocon Limited | Processo para a preparação de teriflunomida |
JOP20190207A1 (ar) * | 2017-03-14 | 2019-09-10 | Actelion Pharmaceuticals Ltd | تركيبة صيدلانية تشتمل على بونيسيمود |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2854439A1 (de) | 1978-12-16 | 1980-07-03 | Hoechst Ag | Ein isoxazolderivat, verfahren zu seiner herstellung, diese verbindung enthaltende mittel und verwendung |
GB8619432D0 (en) | 1986-08-08 | 1986-09-17 | Lilly Industries Ltd | Pharmaceutical compounds |
US5494911A (en) * | 1990-05-18 | 1996-02-27 | Hoechst Aktiengesellschaft | Isoxazole-4-carboxamides and hydroxyalkylidenecyanoacetamides, pharmaceuticals containing these compounds and their use |
ES2124800T3 (es) | 1993-01-08 | 1999-02-16 | Hoechst Ag | Empleo de leflunomida para la inhibicion de interleuquina 1 beta. |
US5610173A (en) * | 1994-01-07 | 1997-03-11 | Sugen, Inc. | Formulations for lipophilic compounds |
PT987256E (pt) * | 1997-08-08 | 2002-03-28 | Aventis Pharma Gmbh | Forma cristalina da n-(4-trifluorometilfenil)-5-metil-isoxazol-4-carboxamida |
DE19908527C2 (de) * | 1999-02-26 | 2001-08-30 | Aventis Pharma Gmbh | Verfahren zur Kristallisation von N-(4-Trifluormethylphenyl)-5-methyl-isoxazol-4-carboxamid |
IL149792A0 (en) * | 1999-12-16 | 2002-11-10 | Teva Pharma | Novel processes for making and a new crystalline form of leflunomide |
-
2001
- 2001-02-08 ES ES01907127T patent/ES2237553T3/es not_active Expired - Lifetime
- 2001-02-08 CA CA002400290A patent/CA2400290A1/en not_active Abandoned
- 2001-02-08 EP EP01907127A patent/EP1257270B1/en not_active Expired - Lifetime
- 2001-02-08 US US09/779,928 patent/US6723855B2/en not_active Expired - Fee Related
- 2001-02-08 KR KR1020027010595A patent/KR20020072312A/ko not_active Application Discontinuation
- 2001-02-08 JP JP2001559460A patent/JP2004500380A/ja active Pending
- 2001-02-08 AU AU2001234943A patent/AU2001234943A1/en not_active Abandoned
- 2001-02-08 SK SK1299-2002A patent/SK12992002A3/sk unknown
- 2001-02-08 AT AT01907127T patent/ATE292966T1/de not_active IP Right Cessation
- 2001-02-08 YU YU61602A patent/YU61602A/sh unknown
- 2001-02-08 DE DE60110043T patent/DE60110043T2/de not_active Expired - Fee Related
- 2001-02-08 HU HU0301865A patent/HUP0301865A3/hu unknown
- 2001-02-08 PL PL01366088A patent/PL366088A1/xx not_active Application Discontinuation
- 2001-02-08 IL IL15119601A patent/IL151196A0/xx unknown
- 2001-02-08 WO PCT/US2001/004095 patent/WO2001060363A1/en not_active Application Discontinuation
- 2001-02-08 CZ CZ20023024A patent/CZ20023024A3/cs unknown
-
2002
- 2002-08-14 ZA ZA200206494A patent/ZA200206494B/en unknown
- 2002-08-14 HR HRP20020671 patent/HRP20020671A2/hr not_active Application Discontinuation
-
2003
- 2003-12-10 US US10/730,949 patent/US20040127532A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP1257270B1 (en) | 2005-04-13 |
HRP20020671A2 (en) | 2004-12-31 |
CA2400290A1 (en) | 2001-08-23 |
CZ20023024A3 (cs) | 2003-05-14 |
ES2237553T3 (es) | 2005-08-01 |
US6723855B2 (en) | 2004-04-20 |
AU2001234943A1 (en) | 2001-08-27 |
DE60110043D1 (de) | 2005-05-19 |
JP2004500380A (ja) | 2004-01-08 |
HUP0301865A2 (hu) | 2003-09-29 |
US20040127532A1 (en) | 2004-07-01 |
SK12992002A3 (sk) | 2003-05-02 |
EP1257270A4 (en) | 2003-05-07 |
DE60110043T2 (de) | 2006-03-02 |
PL366088A1 (en) | 2005-01-24 |
IL151196A0 (en) | 2003-04-10 |
ATE292966T1 (de) | 2005-04-15 |
YU61602A (sh) | 2006-01-16 |
US20020022646A1 (en) | 2002-02-21 |
WO2001060363A1 (en) | 2001-08-23 |
EP1257270A1 (en) | 2002-11-20 |
KR20020072312A (ko) | 2002-09-14 |
ZA200206494B (en) | 2003-08-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EG24141A (en) | Method for preparing a composition | |
HK1042956A1 (zh) | 一種進行數據轉換說明的方法 | |
GB0022525D0 (en) | Process for making a foam component | |
GB0022496D0 (en) | Process for making a foam component | |
IL149292A0 (en) | Method for graphically defining a formula | |
HK1053129A1 (zh) | 治療變態反應的方法 | |
AU2002220625A1 (en) | Method for producing a strip-shaped object | |
GB0010957D0 (en) | Compound & method | |
GB2372575B (en) | Method for forming a sachet | |
HUP0301865A3 (en) | A method for synthesizing leflunomide | |
HUP0104566A3 (en) | Process for producing n-carboxi-anhidrides | |
PL361146A1 (en) | Method for producing isocyanato-organosilanes | |
HUP0102967A3 (en) | Method for producing organosilylalkyl-polysulphanes | |
PL362280A1 (en) | Process for making a toothbrush | |
IL153607A0 (en) | Method for producing aldehydes | |
AU3995001A (en) | Method for a knowledge model | |
GB0018839D0 (en) | Method for process-driven knowledge activation | |
HK1047735A1 (en) | Method for decorating molding | |
IL154825A0 (en) | A METHOD FOR PRODUCING Delta1-PYRROLINES | |
EP1250310A4 (en) | PROCESS FOR SYNTHESIZING HYDRAZODICARBONAMIDE | |
GB0014546D0 (en) | A novel process | |
AU4663601A (en) | Method for preparing 9-deoxo-8a-aza-(8a-alkyl)-8a-homoerythromycin derivativesfrom 9-deoxo-9(z)-hydroxyiminoerythromycin | |
HUP0104629A3 (en) | Method for producing cyclopropanecarboxylates | |
AU7265900A (en) | Method for producing otoplastics | |
AU8444201A (en) | Process for producing fluoroalkanol |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA9A | Lapse of provisional patent protection due to relinquishment or protection considered relinquished |